MSF welcomes addition of new diabetes medicines to WHO Essential Medicines List

MSF welcomes addition of new diabetes medicines to WHO Essential Medicines List

MSF welcomes addition of new diabetes medicines to WHO Essential Medicines List Key diabetes treatments must be available and affordable for people who need them, no matter where they live. Kate Rankin September 5 2025, 2:58pm When a medicine is added to the WHO’s EML, it signals that it is vital for public health and should be made affordable and accessible, that countries should include it in national policies, and that corporations should r…

WHO adds rapid-acting insulin analogues and GLP-1 receptor agonists to EML - Express Healthcare

The World Health Organisation’s (WHO) has announced the inclusion of rapid-acting insulin analogues and GLP-1 receptor agonists (GLP-1 RAs) in the updated Model List of Essential Medicines (EML). People living with type 2 diabetes also need access to insulin-sparing regimens and medicines that have been demonstrated to reduce mortality. The addition of GLP-1 receptor agonists—semaglutide, dulaglutide, liraglutide, and the dual GLP-1/GIP receptor…

WHO updates essential medicines list with new cancer and diabetes treatments

World Health Organization (WHO) has unveiled updated versions of its Model Lists of Essential Medicines (EML) and Essential The post WHO updates essential medicines list with new cancer and diabetes treatments appeared first on National Accord Newspaper.

WHO drops list of essential medicines for cancer, diabetes treatments - Worldstage

The World Health Organisation (WHO) on Friday released updated editions of its Model Lists of Essential Medicines (EML) and Essential Medicines for Children (EMLc). The lists now include new treatments for several cancers and for diabetes with comorbidities such as obesity. Medicines for cystic fibrosis, psoriasis, haemophilia, and blood-related disorders were also added. The WHO EML and EMLc highlight medicines for priority health needs. Adopt…